Treatment adherence therapy in people with psychotic disorders:Randomised controlled trial

BackgroundInterventions to improve adherence to treatment in people with psychotic disorders have produced inconclusive results. We developed a new treatment, treatment adherence therapy (TAT), whose intervention modules are tailored to the reasons for an individual's non-adherence.AimsTo examine the effectiveness of TAT with regard to service engagement and medication adherence in out-patients with psychotic disorders who engage poorly.MethodRandomised controlled study of TAT v. treatment as usual (TAU) in 109 out-patients. Most outcome measurements were performed by masked assessors. We used intention-to-treat multivariate analyses (Dutch Trial Registry: NTR1159).ResultsTreatment adherence therapy v. TAU significantly benefited service engagement (Cohen's d=0.48) and medication adherence (Cohen's d=0.43). Results remained significant at 6-month follow-up for medication adherence. Near-significant effects were also found regarding involuntary readmissions (1.9% v. 11.8%, P=0.053). Symptoms and quality of life did not improve.ConclusionsTreatment adherence therapy helps improve engagement and adherence, and may prevent involuntary admission.